A startup that runs one of the world’s largest health-care digital platforms is seeking to leverage artificial intelligence to capitalize on its trove of medical data, potentially ushering in a new era for diagnostics and positioning the firm for a public listing.
Docplanner, founded in Poland in 2012 to operate an online platform for booking doctor’s appointments, currently connects 100 million monthly users with 2.8 million medical professionals. Subject to patient consent, the company plans to use the data to create medical files which AI models could analyze to enhance diagnostics, co-founder and Chief Executive Officer
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.